Highlights SoftMedx Healthcare Limited

Equities

648 HK0000375797

Market Closed - Hong Kong S.E. Other stock markets 03:08:44 2019-02-21 am EST			5-day change	1st Jan Change
0.38 ^HKD	-.--%		-.--%	-.--%

Apr. 25	SoftMedx Healthcare Returns to Profit in 2023	MT
Mar. 27	SoftMedx Healthcare Limited Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

SoftMedx Healthcare Returns to Profit in 2023	Apr. 25	MT
SoftMedx Healthcare Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 27	CI
Hong Kong High Court Dismisses Winding-Up Petition Against SoftMedx Healthcare	Jan. 24	MT
Winding-Up Petition Hearing Against SoftMedx Healthcare Further Adjourned by Hong Kong Court	Dec. 04	MT
Winding-Up Hearing Against SoftMedx Healthcare Further Adjourned	Dec. 01	MT
Winding-Up Petition Hearing Against SoftMedx Healthcare Adjourned	Nov. 09	MT
SoftMedx Healthcare Limited Reports Earnings Results for the Half Year Ended June 30, 2023	Nov. 05	CI
Winding-Up Petition Hearing Against SoftMedx Healthcare Adjourned to November	23-10-16	MT
Winding-Up Petition Against SoftMedx Healthcare Adjourned to October	23-07-03	MT
SoftMedx Healthcare Hit with Winding-Up Petition	23-04-25	MT
China Wah Yan Healthcare Limited Announces Unaudited Consolidated Earnings Results for the Year Ended December 31, 2017	18-06-26	CI
China Wah Yan Healthcare Limited Provides Earnings Guidance for the Full Year Ended December 31, 2017	18-01-09	CI
China Wah Yan Healthcare Limited Reports Unaudited Consolidated Earnings Results for the Six Months Ended June 30, 2017	17-08-24	CI
Liu Xiaolin completed the acquisition of an additional 51.5% stake in Rui Kang Pharmaceutical Group Investments Limited from China Wah Yan Healthcare Limited.	17-07-30	CI
China Wah Yan Healthcare Ltd. cancelled the acquisition of Xinhua News Media Holdings Ltd. from a group of shareholders'.	17-07-18	CI
Liu Xiaolin entered into a sale and purchase agreement to acquire an additional 51.5% stake in Rui Kang Pharmaceutical Group Investments Limited from China Wah Yan Healthcare Limited for approximately HKD 210 million.	17-06-14	CI
China Wah Yan Healthcare Limited Reports Unaudited Consolidated Earnings Results for the First Quarter Ended 31 March 2017	17-05-19	CI
China Wah Yan Healthcare Limited Announces Audited Consolidated Cash Flow Results for the Year Ended December 31, 2016	17-04-19	CI
An investment holding company cancelled the acquisition of Yezhi Limited from China Wah Yan Healthcare Limited.	17-03-21	CI
China Wah Yan Healthcare Limited Reports Audited Consolidated Earnings Results for the Year Ended December 31, 2016	17-03-20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights SoftMedx Healthcare Limited

Equities

648

HK0000375797

Highlights

Filters